The Latest Breaking News from Merck

Merck & Co. stock was pummeled by 10% after its earnings release on soft forecasts, but the overreaction by the market may present a buying opportunity.

A fresh crop of shareholder proposals that would have once been unremarkable are now a closely watched battlefront in the war against corporate diversity and inclusion initiatives.

Recent market reaction to Trump administration policy announcements has been "entirely normal."

The Nasdaq dominated the major indexes Tuesday. Costco hit a new high and is in a buy zone.

Merck has considerably underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

The Dow Jones dropped Tuesday as China imposed tariffs on U.S. imports in response to President Trump's tariffs. Palantir surged on earnings.

Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.

March S&P 500 E-Mini futures (ESH25) are down -0.01%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.08% this morning as investors awaited the latest reading on U.S. job openings, comments from Federal Reserve officials, and corporate earnings reports from heavyweight names.

March S&P 500 E-Mini futures (ESH25) are down -0.21%, and March Nasdaq 100 E-Mini futures (NQH25) are down -0.11% this morning as investors adopted a cautious stance after China retaliated to new U.S. tariffs.